Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors

被引：0
|
作者：
Immanuel Augustin Oppolzer
Josef Riester
Roland Büttner
Maximilian Burger
Marco Julius Schnabel
机构：
[1] University of Regensburg,Department of Urology
[2] Caritas St. Josef Medical Center,undefined
[3] Department of Internal Medicine Caritas St. Josef Medical Center,undefined
来源：
International Urology and Nephrology | 2023年 / 55卷
关键词：
Kidney Cancer, Bladder Cancer, immune-related adverse events; Hypophysitis; Checkpoint inhibition; PD-1; PD-L1; CTLA-4;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1943 / 1949
页数：6
相关论文
共 50 条
  • [1] Endocrine immune-related adverse events in patients with metastatic renal and urothelial cancer treated with immune checkpoint-inhibitors
    Oppolzer, Immanuel Augustin
    Riester, Josef
    Buettner, Roland
    Burger, Maximilian
    Schnabel, Marco Julius
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (08) : 1943 - 1949
  • [2] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sandigursky, Sabina
    Mor, Adam
    [J]. CURRENT RHEUMATOLOGY REPORTS, 2018, 20 (10)
  • [3] Immune-Related Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sabina Sandigursky
    Adam Mor
    [J]. Current Rheumatology Reports, 2018, 20
  • [4] Immune-Related Adverse Events and Clinical Outcomes in Advanced Urothelial Cancer Patients Treated With Immune Checkpoint Inhibitors
    Sanda, Gregory E.
    Shabto, Julie M.
    Goyal, Subir
    Liu, Yuan
    Martini, Dylan J.
    Nazha, Bassel
    Brown, Jacqueline T.
    Yantorni, Lauren B.
    Russler, Greta Anne
    Caulfield, Sarah
    Joshi, Shreyas S.
    Narayan, Vikram M.
    Kissick, Haydn
    Ogan, Kenneth
    Master, Viraj A.
    Carthon, Bradley C.
    Kucuk, Omer
    Bilen, Mehmet Asim
    [J]. ONCOLOGIST, 2023, : 1072 - 1078
  • [5] Biomarkers for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors
    Liang, Yao
    Maeda, Osamu
    Ando, Yuichi
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, : 365 - 375
  • [6] Immune-related adverse events in cancer patients being treated with immune checkpoint inhibitors
    Byrne, Margaret M.
    Lucas, Mathew
    Pai, Lori
    Breeze, Janis
    Parsons, Susan K.
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (06) : 650 - 657
  • [7] Immune Checkpoint Inhibitors and Immune-Related Adverse Renal Events
    Herrmann, Sandra M.
    Perazella, Mark A.
    [J]. KIDNEY INTERNATIONAL REPORTS, 2020, 5 (08): : 1139 - 1148
  • [8] Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
    Martini, Dylan J.
    Goyal, Subir
    Liu, Yuan
    Evans, Sean T.
    Olsen, T. Anders
    Case, Katherine
    Magod, Benjamin L.
    Brown, Jacqueline T.
    Yantorni, Lauren
    Russler, Greta Anne
    Caulfield, Sarah
    Goldman, Jamie M.
    Nazha, Bassel
    Harris, Wayne B.
    Kissick, Haydn T.
    Master, Viraj A.
    Kucuk, Omer
    Carthon, Bradley C.
    Bilen, Mehmet Asim
    [J]. ONCOLOGIST, 2021, 26 (10): : E1742 - E1750
  • [9] Oral manifestations of immune-related adverse events in cancer patients treated with immune checkpoint inhibitors
    Klein, Brittany A.
    Alves, Fabio Abreu
    de Santana Rodrigues Velho, Julia
    Vacharotayangul, Piamkamon
    Hanna, Glenn J.
    LeBoeuf, Nicole R.
    Shazib, Muhammad Ali
    Villa, Alessandro
    Woo, Sook-Bin
    Sroussi, Herve
    Sonis, Stephen
    Treister, Nathaniel S.
    [J]. ORAL DISEASES, 2022, 28 (01) : 9 - 22
  • [10] Immune-Related Adverse Events and Survival Among Patients With Metastatic NSCLC Treated With Immune Checkpoint Inhibitors
    Cook, Sarah
    Samuel, Vanessa
    Meyers, Daniel E.
    Stukalin, Igor
    Litt, Ishjot
    Sangha, Randeep
    Morris, Don G.
    Heng, Daniel Y. C.
    Pabani, Aliyah
    Dean, Michelle
    Navani, Vishal
    [J]. JAMA NETWORK OPEN, 2024, 7 (01) : E2352302
12345